Population Health Sciences

You are here

Publications

Found 68 results
Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is V  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Venkatesan T, Levinthal DJ, Li BUK, Tarbell SE, Adams KA, Issenman RM, Sarosiek I, Jaradeh SS, Sharaf RN, Sultan S et al..  2019.  Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.. Neurogastroenterol Motil. 31 Suppl 2:e13606.
Shoag JE, Gaffney C, Pantuck M, Sun T, Gorin M, Schaeffer E, Sedrakyan A, Vickers A, Hu J.  2020.  Risk Factors for Infection after Prostate Biopsy in the United States.. Urology. 138:113-118.
Zang C, Hou Y, Schenck E, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, Nordvig A et al..  2023.  Risk Factors and Predictive Modeling for Post-Acute Sequelae of SARS-CoV-2 Infection: Findings from EHR Cohorts of the RECOVER Initiative.. Res Sq.
Rosenkranz KM, Ballman K, McCall L, Kubicky CDai, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B et al..  2019.  Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol. 26(2):702.
Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al..  2019.  Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.
Bond AM, Volpp KG, Emanuel EJ, Caldarella K, Hodlofski A, Sacks L, Patel P, Sokol K, Vittore S, Calgano D et al..  2019.  Real-time Feedback in Pay-for-Performance: Does More Information Lead to Improvement? J Gen Intern Med.
P
Xie Y, Valdimarsdóttir UA, Wang C, Zhong XR, Gou Q, Zheng H, Deng L, He P, Hu K, Fall K et al..  2020.  Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China.. Int J Cancer.
Jung H-Y, Gichoya JWawira, Vest JR.  2017.  Providers' Access of Imaging Versus Only Reports: A System Log File Analysis.. J Am Coll Radiol. 14(2):217-223.
Lin M, Liu L, Gordon M, Kass M, Wang F, Van Tassel SH, Peng Y.  2022.  Primary Open-Angle Glaucoma Diagnosis from Optic Disc Photographs Using a Siamese Network.. Ophthalmol Sci. 2(4):100209.
Lazow SP, Venn RA, Lubor B, Kocharian G, Kreines FM, Gilbert E, Marnell CS, Cricco-Lizza E, Cooley V, Christos P et al..  2019.  The PreOp Program: Intensive Preclinical Surgical Exposure is Associated With Increased Medical Student Surgical Interest and Competency.. J Surg Educ.
Adekkanattu P, Rasmussen LV, Pacheco JA, Kabariti J, Stone DJ, Yu Y, Jiang G, Luo Y, Brandt PS, Xu Z et al..  2023.  Prediction of left ventricular ejection fraction changes in heart failure patients using machine learning and electronic health records: a multi-site study.. Sci Rep. 13(1):294.
Jung H-Y, Unruh MAaron, Vest JR, Casalino LP, Kern LM, Grinspan ZM, Bao Y, Kaushal R.  2017.  Physician Participation in Meaningful Use and Quality of Care for Medicare Fee-for-Service Enrollees.. J Am Geriatr Soc. 65(3):608-613.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al..  2019.  Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.
Vest JR, Kern LM, Jung H-Y, Ancker JS, Richardson JE, Silver MD, Kaushal R.  2015.  Patient-centered medical homes: observable types derived from national recognition assessment scores.. J Ambul Care Manage. 38(2):144-52.